STAT

Opinion: Uninsured Americans were ignored when Congress grilled pharma execs

"Nobody" pays list prices for drugs — except people who can afford it the least, including the 27 million Americans who don't have health insurance.
An uninsured woman gets her blood pressure checked by a volunteer at a free medical clinic in New Orleans sponsored by the National Association of Free & Charitable Clinics. There are currently there are 27 million Americans without insurance.

Seven top pharma executives testified before Congress on Tuesday about the rising cost of medications in what some had predicted to be a watershed moment for the pharmaceutical industry. They were grilled about their pricing process, profit margins, and even their own salaries as lawmakers expressed outrage about high drug prices, including those for the lifesaving, necessary medications that so many Americans are now struggling to afford.

But that conversation, and the lawmakers’ outrage, centered around a specific group

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Abortion Pill Arguments, A Merck Drug Approval, And More
U.S. Supreme Court justices focused on plaintiffs' right to sue the FDA to reinstate restrictions on a commonly used abortion pill, suggesting they are unlikely to restrict access.
STAT1 min read
STAT+: New Gene Therapy, To Be Priced At $4.25 Million, Has Already Transformed Children’s Lives
The world's most expensive treatment offers a near-cure for young children and redemption for its developer, but steep challenges still loom.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CAR-T Drugs For Myeloma, CVS Rebate Credits, And More
A FDA panel voted in favor of expanding use of CAR-T therapy in multiple myeloma, despite concerns about side effects.

Related Books & Audiobooks